Our unparalleled network of Key Opinion Leaders, Subject Matter Experts, and x-FDA consultants is here to serve you. Drug development has changed dramatically, emphasizing engagement with a broader set of experts and an expanded focus on value-based therapies. Demonstrating real-world value beyond regulatory approval is the new symbol of pharmaceutical industry success.
Our Medical Affairs support services include:
KOL Mapping and Engagement Strategy
Scientific Advisory Board management
Subject matter training and continuing medical education and communication
Medical Intelligence and insight on indication, subject population, inclusion/exclusion criteria, known adverse events, drug class, and concurrent or adjunct medications
24/7 access to global Medical Monitors and Safety Physicians
Medical Monitor and Safety Management Plan Generation
Contact our medical affairs team to get the support your program deserves.